Systemic-Lupus-Erythematosus-Related Acute Pancreatitis: A Cohort from South China

Table 1

The demographic and clinical characteristics of each SLE patient with AP.

Case	Age at SLE onset (y)	Duration between onset of SLE and AP (m)	SLEDAI score at onset of AP	Number of involved organs concomitant with AP	GC treatment after onset of AP	Outcome
1	23	0.5	9	5	Increased dose	In remission
2	16	48	12	4	Stop	In remission
3	18	12	14	6	Increased dose	Died
4	22	72	14	7	Increased dose	In remission
5	16	36	16	7	Increased dose	In remission
6	57	24	17	4	Increased dose	In remission
7	36	0.5	17	6	Initial treatment	Died
8	48	180	18	7	maintaining	Died
9	14	36	21	4	maintaining	Died
10	14	12	23	7	Increased dose	Died
11	19	2	23	6	Increased dose	In remission
12	14	2	27	7	Increased dose	Died
13	46	1	25	4	Increased dose	In remission
14	22	0.25	18	3	Decreased dose	In remission
15	51	240	18	6	Decreased dose	In remission
16	42	4	19	7	Increased dose	In remission
17	20	84	18	5	Decreased dose	Died
18	39	24	13	5	Increased dose	In remission
19	15	2	33	6	Decreased dose	Died
20	15	36	41	7	Increased dose	In remission
21	26	3	41	8	Increased dose	Died
22	39	1	27	6	Increased dose	In remission
23	20	72	10	3	maintaining	In remission
24	36	12	38	6	maintaining	Died
25	16	2	8	3	Increased dose	In remission
26	30	48	47	8	Increased dose	In remission
27	14	72	19	6	maintaining	In remission